🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Thank you Andrew Krahn and team for inviting me to be the keynote speaker at #CIED2024! Honored to share our NIH NHLBI-funded work on using AI to expand the utility of implantable devices, beyond diagnostics to guiding AF treatment SafeBeat Rx UCSF Cardiology reunion #Vancouver

So proud of our founder Rachita Navara, MD FACC FHRS for delivering the keynote at #CIED2024! It is exciting to see how our NIH NHLBI- funded research is shaping the future of #AFib treatment by leveraging AI and implantable devices. 👏 #DigitalHealth #Innovation

October is #SuddenCardiacArrest Awareness Month Check out this important TikTok video featuring our founders, @kunjgpatel and Rachita Navara, MD FACC FHRS on how to respond to sudden cardiac arrest with hands-only CPR. Every second counts! bit.ly/3UtonIt

We are thrilled to announce the publication of "State of the Art of Mobile Health Technologies Use in Clinical Arrhythmia Care," co-authored by Rachita Navara, MD FACC FHRS Check it out here: bit.ly/48uL84C Congrats to all the authors for their hard work and collaboration!

We are thrilled to announce the publication of "State of the Art of Mobile Health Technologies Use in Clinical Arrhythmia Care," co-authored by Rachita Navara, MD FACC FHRS Check it out here: bit.ly/48uL84C Congrats to all the authors for their hard work and collaboration!

We are thrilled to announce the publication of "State of the Art of Mobile Health Technologies Use in Clinical Arrhythmia Care," co-authored by Rachita Navara, MD FACC FHRS Congrats to all the authors for their hard work and collaboration! Check it out here: bit.ly/48uL84C

Excited to share that our CEO, Rachita Navara, MD FACC FHRS co-authored an article titled "The Evolution of Electrophysiology: 57 Years of Milestones" in American College of Cardiology Magazine with Estelle Torbey. Discover the remarkable advancements in our field over the years. bit.ly/4ftwAEq

We are thrilled to be presenting at the NHBLI AHA Company Showcase on November 18 during the #AHA24 AHA Science, in addition to the original research session on Nov 18. Join us in Chicago to learn more about our innovations in digital health. NIH NHLBI

We are honored to have had the opportunity to present at #AHA24. Our team shared research and participated in the NIH NHLBI Company Showcase, highlighting our work in advancing cardiac care. Grateful to connect with the inspiring #cardiology community AHA Science

We’re excited and grateful to share that SafeBeat will be at the 30th Annual AF Symposium 2025! Join us on Jan 16-18 at the Omni Boston at the Seaport, where we’ll present 3 accepted abstracts showcasing our work in #AFib care. Can’t wait to connect with you all! #AFSymposium2025

What an incredible week at the 30th Annual #AFSymposium2025 in Boston! SafeBeat Rx is grateful to have been part of this milestone event. Thank you to everyone who made this year's AF symposium so impactful—here’s to many more years of innovation and collaboration!

Exciting news! We have been awarded a supplement award under our Phase II SBIR grant from NIH NHLBI and in collaboration with @ucsf! This funding supports Dr. Margaret Ferrari, Ph.D., our Post-doc Fellow, and will support advancing her career development in cardiac innovation.

Excited to announce that our founders, Kunj G. Patel, MD, MSc and Rachita Navara, MD FACC FHRS, will be at #ACC25! Join us as we drive the conversation on cardiovascular innovation and AI-driven solutions. See you there! American College of Cardiology JACC Journals

Honored to be part of this all-star panel on contemporary management of AFib at #ACC25 🔑 Takeaways: refer to EP early after AF diagnosis, take wearable device-detected AF seriously, avoid cardioversion without antiarrhythmics, and monitor monitor monitor! American College of Cardiology SafeBeat Rx

So proud of our SafeBeat Rx research team #ACC25 presentation! Our prospective study showed that SafeBeat’s ECG-driven antiarrhythmic dosing recommendations aligned with EP clinical decisions in 93% of #AFib patients. Exciting potential for AI to guide actual clinical workflows!

Thrilled to bring 2 SafeBeat Rx abstracts to #HRS2025 in San Diego (Apr 24–27)! We’re showcasing QTc‑guided drug initiation and the quality of social media #AFib education. Swing by to connect and help advance the future of arrhythmia care! 🫀

Exciting news! BIOTRONIK US has teamed up with SafeBeat Rx to extend AF management using BIOMONITOR IV. Stop by Booth #2005 at #HRS2025 to explore the SafeBeat solution, see live software demos and join our Early Access Program. Learn how we’re advancing heart rhythm care together

So proud of our SafeBeat Rx research team #HRS2025 presentations🫀❤️‍🔥 One of our studies demonstrates that our explainable AI antiarrhythmic dosing platform allows EPs to rapidly approve ECGs (1.1 min) and AAD dosing decisions (2.9 min) in real-time. #Afib #EPeeps Heart Rhythm Society

Thrilled that SafeBeat Rx was selected as a MedTech Innovator showcase company at DeviceTalks Boston! We unveiled our tailored cardiac monitoring platform and shared milestones like completing preclinical validation and launching our first clinical pilots. #MedTechInnovator

Great #longevity talk by Eric Topol for Y Combinator on the importance of rigorous human studies & the promise of AI to extend healthspan through data-driven, personalized interventions. Thanks for your latest book, and excited to keep building the future of cardiology SafeBeat Rx